DarioHealth Corp (NAS:DRIO)
$ 7.74 -0.45 (-5.78%) Market Cap: 75.41 Mil Enterprise Value: 87.22 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 48/100

Q2 2024 DarioHealth Corp Earnings Call Transcript

Aug 08, 2024 / 12:30PM GMT
Release Date Price: $16.7 (-9.94%)

Key Points

Positve
  • DarioHealth Corp (DRIO) reported a 60% sequential growth in its core B2B2C business from Q1 to Q2 2024, with 28% organic growth before the Twill acquisition impact.
  • The company achieved 82% non-GAAP gross margins in its B2B2C business, indicating strong profitability potential.
  • DarioHealth Corp (DRIO) anticipates a 70% reduction in non-GAAP operating losses between Q1 2024 and Q1 2025, aligning with its roadmap to profitability by the end of 2025.
  • The integration of Twill's behavioral health expertise with Dario's platform is driving cross-selling success, with many existing clients adopting the Twill platform.
  • The company's GLP-1 product has seen rapid adoption, with nine clients already on board, enhancing its comprehensive solution for employers and health plans.
Negative
  • DarioHealth Corp (DRIO) issued a $1.1 million price concession impacting its top line for the quarter, which may affect short-term revenue.
  • The company's revenue growth has not fully materialized to expectations, prompting a strategic organizational transformation.
  • There is a temporary slowdown in the pharma channel revenues as the company transitions to a more stable recurring revenue model.
  • The Twill acquisition has not yet resulted in significant revenue growth, as the B2B2C segment experienced mid-single-digit growth in Q2 2024.
  • The company underwent significant headcount reductions and cost-cutting measures, which may impact operations and employee morale.
Operator

Good morning, ladies and gentlemen, and welcome to the DarioHealth second-quarter 2024 results conference call. (Operator Instructions) This call is being recorded on Thursday, August 8, 2024. I would now like to turn the conference over to Kat Parrella, Investor Relations Manager at Dario. Please go ahead.

Kat Parrella
DarioHealth Corp - Investor Relations Manager

Thank you, operator, and good morning, everyone. Thank you for joining us today for a discussion of DarioHealth's second-quarter 2024 financial results. Leading the call today will be Erez Raphael, CEO of DarioHealth. He'll be joined by Steven Nelson, Chief Commercial Officer.

An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Thursday, August 8, 2024. This morning, we had issued a press release announcing our financial results for the second quarter of 2024. A copy of the release can be found on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot